Theracryf Plc (AIM:TCF)
London · Delayed Price · Currency is GBP · Price in GBX 0.1600
-0.0100 (-5.88%)
Sep 25, 2026, 4:26 PM GMT
Theracryf Market Cap
Theracryf has a market cap or net worth of 4.64 million as of September 25, 2026. Its market cap has decreased by -9.12% in one year.
Market Cap
4.64M
Enterprise Value
1.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
ChartMarket Cap Chart
Since October 21, 2015, Theracryf's market cap has decreased from 25.60M to 4.64M, a decrease of -81.85%. That is a compound annual growth rate of -14.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.64M | 8.07% |
| Dec 31, 2025 | 4.30M | 90.55% |
| Dec 31, 2024 | 2.26M | -48.72% |
| Dec 29, 2023 | 4.40M | -64.04% |
| Dec 30, 2022 | 12.23M | -13.59% |
| Dec 31, 2021 | 14.16M | -0.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 12.90M |
| Aptamer Group | 11.23M |
| Genflow Biosciences | 10.90M |
| Solvonis Therapeutics | 7.83M |
| CRISM Therapeutics | 7.72M |
| Cizzle Biotechnology Holdings | 7.22M |
| Thalia Therapeutics | 6.95M |
| OptiBiotix Health | 6.04M |